Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar:197:175-176.
doi: 10.1016/j.ahj.2017.10.020. Epub 2017 Nov 4.

Changes in lipoprotein(a) following bariatric surgery

Bing-Xue Lin  1 , Matthew C Weiss  2 , Manish Parikh  3 , Jeffrey S Berger  4 , Edward A Fisher  1 , Sean P Heffron  5
Affiliations

Changes in lipoprotein(a) following bariatric surgery

Bing-Xue Lin et al. Am Heart J. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest/Financial disclosures: None

Figures

Figure 1.
Figure 1.
Percent change in (A) Lp(a) and (B) ApoB from pre-operative levels at 1 and 6 months post-operatively. Data represented as mean ± SEM.
See this image and copyright information in PMC

References

    1. Padilla N, Maraninchi M, Beliard S, et al. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans - significance. Arterioscler Thromb Vasc Biol 2014;34:2330–7. - PubMed
    1. Chennamsetty I, Claudel T, Kostner KM. et al. Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest 2011;121:3724–34. - PMC - PubMed
    1. Norata GD, Ballantyne CM, Catapano AL. New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. Eur Heart J 2013;34:1783–9. - PMC - PubMed
    1. Desai NR, Kohli P, Giugliano RP, et al. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial. Circulation 2013;128:962–9. - PubMed
    1. Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR. Bile acids and bariatric surgery. Mol Aspects Med 2017;56:75–89. - PMC - PubMed

Publication types